Fenofibrate Capsules Recalled for CGMP Manufacturing Deviations
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Fenofibrate Capsules 67 mg due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects 100-count bottles distributed nationwide.
- Product
- FENOFIBRATE — FENOFIBRATE (FENOFIBRATE)
- Category
- Drug
- Distribution
- Distributed nationwide